Stay updated on Dolutegravir Study in Completing IMPAACT Participants Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.

Latest updates to the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page
- Check6 days agoChange DetectedMinor updates observed (e.g., last updated timestamp and formatting tweaks). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedMajor update to operational notice and a version upgrade to v3.2.0; old v3.1.0 version reference removed.SummaryDifference3%

- Check42 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check71 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed drug information and specific location terms, while retaining the facility name and locations in Brazil and Thailand.SummaryDifference2%

Stay in the know with updates to Dolutegravir Study in Completing IMPAACT Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.